Table 2.
Differences in regional cerebral blood flow between CBD and placebo.
| Region of interest | Δ Perfusion (mL/100 g/min (CI)) | Δ Perfusion (% (CI)) | t14 statistic | Cohen’s d | p | p # |
|---|---|---|---|---|---|---|
| Hippocampus | 15.00 (5.78–24.21) | 12.69 (5.75–19.63) | 3.489 | 0.75 | 0.004** | 0.024* |
| Parahippocampal gyrus | 2.52 (−14.33–19.38) | −0.32 (−13.87–13.23) | 0.792 | 0.09 | 0.441 | 1.000 |
| Amygdala | −3.26 (−13.80–7.29) | −4.31 (−16.48–7.86) | −0.663 | 0.15 | 0.518 | 1.000 |
| Orbitofrontal cortex | 10.04 (1.90–18.19) | 7.02 (1.06–12.97) | 2.644 | 0.55 | 0.019* | 0.095 |
| Ventromedial prefrontal cortex | 5.95 (−1.69–13.60) | 4.55 (−2.76–11.85) | 1.671 | 0.20 | 0.117 | 0.468 |
| Dorsolateral prefrontal cortex | 0.60 (−6.51–7.70) | −0.73 (−7.55–6.08) | 0.180 | 0.02 | 0.860 | 0.860 |
CI: confidence interval.
*
Significant at the p <0.05 level.
**
Significant at the p <0.01 level.
p# = Holm–Bonferroni corrected (using alpha 0.05).